NicoWater washes westward
This article was originally published in The Tan Sheet
Executive Summary
"Homeopathic nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings" will be sold throughout entire Rite Aid chain, Westlake Village, Calif.-based QT 5 announces Nov. 3. Chain is "first major retailer to bring our product to the entire West Coast market as well as many mid-western markets not previously served," firm says. NicoWater has been in distribution in northeast at Eckerd, Rite Aid and other stores since May. Product is marketed as homeopathic drug since objections from FDA quashed launch as dietary supplement (1"The Tan Sheet" March 17, 2003, In Brief). Nicorette gum marketer GlaxoSmithKline filed a citizen petition in March asserting water's potency falls outside legal potency for OTC homeopathics (2"The Tan Sheet" April 7, 2003, p. 7)...
You may also be interested in...
Nicowater OTC Homeopathic Remedy Classification Illegal – GSK
QT5's Nicowater nicotine beverage cannot legally be marketed as an over-the-counter homeopathic product because it contains "too great a concentration of nicotine," GSK asserts in a March 21 1citizen petition filed by Washington, D.C. law firm Ropes & Gray
Nicowater returns
QT5, maker of nicotine-enhanced water, "expects revenue to exceed $20 mil." within first 12 months of product's relaunch as "homeopathic nicotinum formula," Westlake Village, Calif.-based firm says. Clear, odorless water with 4 mg nicotine per 16.9 fl. oz. bottle will debut during Q2 2003 for "smokers who want to smoke but can't." QT5 previously attempted to offer the product as dietary supplement but met with objections from FDA (1"The Tan Sheet" July 8, 2002, p. 8). An "aggressive marketing and advertising campaign" will support the Nicowater launch, QT5 said...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”